Home » Topics » Regulatory » Patents

Patents
RSS

Glaxo Wellcome describes optically active pyrimidine useful as analgesic and anticonvulsant

May 22, 1997

Atypical neuroleptics from Merck KGaA

May 22, 1997

Celgene describes TNF/PDE inhibitors

May 22, 1997

Leukotriene biosynthesis inhibitors from Abbott

May 21, 1997

Excitatory amino acid antagonists disclosed by Glaxo Wellcome

May 21, 1997

PNP inhibitors from Chiroscience for T-cell-mediated disorders

May 21, 1997

Orion-Yhtyma discloses potent and selective alpha2-adrenoceptor agonists

May 21, 1997

Fujisawa describes new cephems

May 21, 1997

MMP/TNF/CD23 inhibitors prepared by Chiroscience

May 21, 1997

Selective thrombin inhibitors revealed by HMR

May 21, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...